000			nab a22 7a 4500
999			_c16062 _d16062
003			PC16062
005			20210318142453.0
008			201005b xxu||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_9387 _aCortijo Cascajares, Susana _eFarmacia
100			_92320 _aRuiz Ares, Gustavo _eOncología Médica
100			_91181 _aCortés-Funes Castro, Hernán _eOncología Médica
100			_92685 _aPernaut Sánchez, Cristina _eOncología Médica
100			_92686 _aOtero Blas, Irene _eOncología Médica
100			_92684 _aRodríguez Garzotto, Analía _eOncología Médica
245	0	0	_aErythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience. _h[artículo]
260			_bJournal of blood medicine, _c2014
300			_a5:43-8
500			_aFormato Vancocuver: Rodriguez Garzotto A, Cortijo Casacajares S, Pernaut C, Ruiz Ares GJ, Otero Blas I, Heine O et al. Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience. J Blood Med. 2014 Apr 28;5:43-8.
501			_aPMID: 24855398; PMC4011805.
505			_aErratum in J Blood Med. 2014;5:129. Cortijo Casacajares, Susana [added]; Pernaut, Cristina [added]; Ruiz Ares, Gustavo Javier [added]; Otero Blas, Irene [added]; Cortes Funes, Hernan [added]
520			_aThe purpose of this paper is to report real-world data on the relative effectiveness of a biosimilar erythropoiesis-stimulating agent (ESA; Binocrit®), and other available ESAs for the treatment of chemotherapy-induced anemia.
710			_9320 _aServicio de Farmacia Hospitalaria
710			_9303 _aServicio de Oncología Médica
856			_uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011805/ _yAcceso libre
942			_2ddc _cART _n0